Tramadol - Toxicology
Due to different CYP-2D6 genotypes, ...
636
Description

Tramadol - Toxicology

Due to different CYP-2D6 genotypes, people variably metabolize tramadol into its active metabolite, M1

This leads to an unpredictable mix of SNRI and opioid effects in patients

 • Ultra-rapid metabolizers

    - Some people are ultra-rapid metabolizers of tramadol (By the same CYP2D6 polymorphism resulting in codeine ultra-rapid metabolism)

    - Death and life threatening respiratory depression have occurred following a single dose of tramadol inchildren

    - Risk of infant respiratory depression in breast-feeding if mother or child are ultra-rapid metabolizers

 • Poor metabolizers - In poor metabolizers, people may experience little, or no analgesic activity as the M1 metabolite cannot be created. (By the same CYP-2D6 polymorphism resulting in poor codeine metabolism and little to no analgesic activity).



By Dr. Kathryn Watson @Kat_Watson



#Tramadol #Toxicology #Toxicity #Diagnosis #Pharmacology
Contributed by

Dr. Gerald Diaz
@GeraldMD
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG:  https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Medical jobs
view all

0 Comments

Related content